A mathematical model of cellular apoptosis and senescence through the dynamics of telomere loss

被引:41
作者
Arkus, N [1 ]
机构
[1] Columbia Univ, Dept Appl Phys & Appl Math, New York, NY 10027 USA
关键词
telomere; TRF2; senescence; apoptosis; telomerase;
D O I
10.1016/j.jtbi.2004.12.016
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The shortening of telomeric repeats as a cell replicates has long been implicated as a determinant of cell viability. However, recent studies have indicated that it is not telomere length, but rather whether telomeres have bound a telomere-related protein, which in mammals is TTAGGG repeat binding factor-2 (TRF2), that determines whether a cell undergoes apoptosis (programmed cell death), enters senescence (a quiescent, non-replicative state), or continues to proliferate. When bound to a telomere, TRF2 allows a cell to recognize the telomere as the point where a chromosome ends rather than a break in DNA. When telomeres are not bound by TRF2, the cell can either immediately trigger senescence or apoptosis via the DNA damage response pathway, or indirectly trigger it by attempting to repair the chromosome, which results in chromosomal end joining. We model the ability of telomeres to bind TRF2 as a function of telomere length and apply the resulting binding probability to a model of cellular replication that assumes a homogeneous cell population. The model fits data from cultured human fibroblasts and human embryonic kidney cells for two free parameters well. We extract values for the percent of telomere loss at which cell proliferation ceases. We show, in agreement with previous experiments, that overexpression of TRF2 allows a cell to delay the senescence setpoint. We explore the effect of oxidative stress, which increases the rate of telomere loss, on cell viability and show that cells in the presence of oxidative stress have reduced lifespans. We also show that the addition of telomerase, an enzyme that maintains telomere length, is sufficient to result in cell immortality. We conclude that the increasing inability of TRF2 to bind telomeres as they shorten is a quantitatively reasonable model for a cause of either cellular apoptosis or senescence. (c) 2005 Published by Elsevier Ltd.
引用
收藏
页码:13 / 32
页数:20
相关论文
共 25 条
[1]   MATHEMATICAL-MODELING OF THE LOSS OF TELOMERE SEQUENCES [J].
ARINO, O ;
KIMMEL, M ;
WEBB, GF .
JOURNAL OF THEORETICAL BIOLOGY, 1995, 177 (01) :45-57
[2]   Comparison of the human and mouse genes encoding the telomeric protein, TRF1: Chromosomal localization, expression and conserved protein domains [J].
Broccoli, D ;
Chong, L ;
Oelmann, S ;
Fernald, AA ;
Marziliano, N ;
vanSteensel, B ;
Kipling, D ;
LeBeau, MM ;
deLange, T .
HUMAN MOLECULAR GENETICS, 1997, 6 (01) :69-76
[3]   A HUMAN TELOMERIC PROTEIN [J].
CHONG, L ;
VANSTEENSEL, B ;
BROCCOLI, D ;
ERDJUMENTBROMAGE, H ;
HANISH, J ;
TEMPST, P ;
DELANGE, T .
SCIENCE, 1995, 270 (5242) :1663-1667
[4]   TELOMERE SHORTENING ASSOCIATED WITH CHROMOSOME INSTABILITY IS ARRESTED IN IMMORTAL CELLS WHICH EXPRESS TELOMERASE ACTIVITY [J].
COUNTER, CM ;
AVILION, AA ;
LEFEUVRE, CE ;
STEWART, NG ;
GREIDER, CW ;
HARLEY, CB ;
BACCHETTI, S .
EMBO JOURNAL, 1992, 11 (05) :1921-1929
[5]   Stabilization of telomere length and karyotypic stability are directly correlated with the level of hTERT gene expression in primary fibroblasts [J].
Cui, W ;
Aslam, S ;
Fletcher, J ;
Wylie, D ;
Clinton, M ;
Clark, AJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (41) :38531-38539
[6]   Protection of mammalian telomeres [J].
de Lange, T .
ONCOGENE, 2002, 21 (04) :532-540
[7]   Structure of the TRFH dimerization domain of the human telomeric proteins TRF1 and TRF2 [J].
Fairall, L ;
Chapman, L ;
Moss, H ;
de Lange, T ;
Rhodes, D .
MOLECULAR CELL, 2001, 8 (02) :351-361
[8]   TELOMERE LOSS - MITOTIC CLOCK OR GENETIC TIME BOMB [J].
HARLEY, CB .
MUTATION RESEARCH, 1991, 256 (2-6) :271-282
[9]   RETESTING THE COMMITMENT THEORY OF CELLULAR AGING [J].
HARLEY, CB ;
GOLDSTEIN, S .
SCIENCE, 1980, 207 (4427) :191-193
[10]   The illusion of cell immortality [J].
Hayflick, L .
BRITISH JOURNAL OF CANCER, 2000, 83 (07) :841-846